Expression of Mesothelin in Thymic Carcinoma and its Potential Therapeutic Significance

OBJECTIVES: Advanced thymic epithelial tumors (TETs) lack adequate treatment options in part due to absence of well characterized tumor-specific antigens. Mesothelin, a cell surface antigen, has been used successfully as a target for tumor-directed therapy. We sought to determine tumor expression an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lung Cancer
Autors principals: Thomas, Anish, Chen, Yuanbin, Berman, Arlene, Schrump, David S., Giaccone, Giuseppe, Pastan, Ira, Venzon, David J., Liewehr, David J., Steinberg, Seth M., Miettinen, Markku, Hassan, Raffit, Rajan, Arun
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7804607/
https://ncbi.nlm.nih.gov/pubmed/27794397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2016.09.015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars